Mumbai-based Advanced Enzyme Technologies Ltd, the largest manufacturer of enzymes in the country, will invest Rs 115 crore to set up three biotech production facilities.
The company reportedly in talks with a dozen firms overseas for an acquisition.
Board meetings of two holding companies stayed.
Iron ore prices are expected to fall in next couple of months following the imposition of duties on exports.
With the bidding for the generics business of Merck set to begin from Monday, domestic pharmaceutical companies in the fray, Ranbaxy Laboratories and Dr Reddy's Laboratories, are unlikely to go for an all-out bidding war.
Spectrum Retail Mart, a retail chain of medical stores and fast moving consumer goods, has set up shop in Mumbai with an initial investment of over Rs 90 crore (Rs 900 million).
Sources close to the development said Lavazza would acquire the majority stake in Barista from ace investor C Sivasankaran
After being raided by Federal officials, Ranbaxy Laboratories Ltd, India's largest pharmaceutical company, has been taken to court in the US by a consumer health group that supports the sale of low-priced generic medicines.
In a move aimed at consolidating its Indian operations, Swiss cement major Holcim will increase its control in ACC and Gujarat Ambuja Cements for close to Rs 2,700 crore (Rs 27 billion).
The Indian company that acquires Merck Generics, the multinational drug maker's generics (non-patented) business, up for sale, will be able to compete against the top global players
Tata Steel may opt for a rights issue to raise funds to finance its $13.13 billion purchase of the Corus group
Although both parties were tightlipped on the details of the lawsuit, which was served on the company's US subsidiary this week, sources in the know said its financial implications would be huge if the court verdict goes against Novelis.
Continuing with its move to position itself as a beverage marketing company, Tata Tea is set to divest 80 per cent in its North Indian Plantation Operations, which is being spun off to a handful of investors and workers.
Mumbai-based pharmaceutical company Indoco Remedies Ltd plans to tap the regulated markets of Europe and the US.
Corus Group chairman Jim Leng will receive an addition payment of pound 750,000 (Rs 6.41 crore) for turning around the Anglo-Dutch steel maker in the past two years.
The Mumbai-based Arch Pharma has raised $27 million from private equity funding in the last four years
Suzlon's Rs 6,000 crore (Rs 60 billion) bid to acquire Germany's third largest wind turbine maker REpower could well turn into a bidding war
In Mumbai, Reliance Health Venture has already acquired the Mandke hospital, which will be converted into a 650-bed super specialty hospital with six divisions.
The proposed company could rope in former CEO of Star TV Peter Mukerjea and Mukesh Ambani.
As many as 15 companies across the world have lined up generic variants of Pfizer's Zoloft (Sertaline HCL), for which the exclusive six-month marketing period granted to the successful patent challenger, Teva of Israel, ends on Tuesday.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances